Today, Seema Sahay is Head of Division of Social Behavioural Research at the Indian Council of Medical Research, National Institute of Translational Virology & AIDS Research (NARI), Pune, India.

Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

A man accused of deliberately infecting seven young men with HIV lied to sexual partners that he was "clean", a court has ...

A revolutionary test is transforming dementia care. Days after a simple blood test, a person with dementia can learn whether they have Alzheimer’s disease. At least six companies sell these tests ...

Malawian student Kondwani has fought against the stigma of being HIV-positive for most of his life, but COVID-19 has reignited old prejudices and given rise to a new term of abuse - "corona carrier".

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...

Merck (NYSE:MRK) reported positive results from late-stage studies on a new oral treatment which combines two drugs, doravirine and islatravir, for adults with HIV-1. The studies looked at adults ...

Kameron Gilchrest is charged with assaulting emergency personnel after allegedly spraying his HIV-positive blood at hospital staff in North Carolina. He faces multiple counts and a court date in ...

RALEIGH, N.C. (WKRC) — A hospital patient allegedly removed an IV from his arm and used his "HIV positive blood" as a weapon by spraying it into the eyes of medical personnel. According to an arrest ...

Among pregnant women with HIV infection, oral rilpivirine-based antiretroviral regimens were associated with similar rates of adverse pregnancy and birth outcomes as nonrilpivirine regimens. The ...